Cargando…
Enabling allogeneic therapies: CIRM‐funded strategies for immune tolerance and immune evasion
A major goal for the field of regenerative medicine is to enable the safe and durable engraftment of allogeneic tissues and organs. In contrast to autologous therapies, allogeneic therapies can be produced for many patients, thus reducing costs and increasing availability. However, the need to overc...
Autores principales: | Kadyk, Lisa C., Okamura, Ross M., Talib, Sohel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445020/ https://www.ncbi.nlm.nih.gov/pubmed/32585084 http://dx.doi.org/10.1002/sctm.20-0079 |
Ejemplares similares
-
CIRM tools and technologies: Breaking bottlenecks to the development of stem cell therapies
por: Collins, Lila R., et al.
Publicado: (2020) -
Proceedings: Regenerative Medicine for Lung Diseases: A CIRM Workshop Report
por: Kadyk, Lisa C., et al.
Publicado: (2017) -
M7824: A promising new strategy to combat cancer immune evasion
por: Gatti-Mays, Margaret E., et al.
Publicado: (2018) -
Unleashing the cure: Overcoming persistent obstacles in the translation and expanded use of hematopoietic stem cell‐based therapies
por: Talib, Sohel, et al.
Publicado: (2020) -
CIME-CIRM Summer-School
por: Conca, Aldo, et al.
Publicado: (2014)